Outset Medical Inc (NASDAQ: OM) on Friday, soared 7.02% from the previous trading day, before settling in for the closing price of $0.57. Within the past 52 weeks, OM’s price has moved between $0.44 and $6.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 202.67%. The company achieved an average annual earnings per share of 28.19%. With a float of $47.80 million, this company’s outstanding shares have now reached $50.32 million.
Considering the fact that the conglomerate employs 480 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 28.23%, operating margin of -129.25%, and the pretax margin is -136.28%.
Outset Medical Inc (OM) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Outset Medical Inc is 8.24%, while institutional ownership is 93.78%. The most recent insider transaction that took place on Aug 15 ’24, was worth 4,459. In this transaction Chair and CEO of this company sold 5,308 shares at a rate of $0.84, taking the stock ownership to the 910,496 shares. Before that another transaction happened on Aug 15 ’24, when Company’s SVP Operations and R&D sold 1,293 for $0.84, making the entire transaction worth $1,086. This insider now owns 239,397 shares in total.
Outset Medical Inc (OM) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 28.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.80% during the next five years compared to -15.08% drop over the previous five years of trading.
Outset Medical Inc (NASDAQ: OM) Trading Performance Indicators
Outset Medical Inc (OM) is currently performing well based on its current performance indicators. A quick ratio of 5.38 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.14, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -1.39 in one year’s time.
Technical Analysis of Outset Medical Inc (OM)
Compared to the last year’s volume of 1.34 million, its volume of 0.65 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 60.25%. Additionally, its Average True Range was 0.05.
During the past 100 days, Outset Medical Inc’s (OM) raw stochastic average was set at 3.97%, which indicates a significant decrease from 76.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.05% in the past 14 days, which was lower than the 210.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5725, while its 200-day Moving Average is $2.4694. Nevertheless, the first resistance level for the watch stands at $0.6445 in the near term. At $0.6789, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7212. If the price goes on to break the first support level at $0.5678, it is likely to go to the next support level at $0.5255. Should the price break the second support level, the third support level stands at $0.4911.
Outset Medical Inc (NASDAQ: OM) Key Stats
Market capitalization of the company is 34.00 million based on 52,090K outstanding shares. Right now, sales total 130,380 K and income totals -172,800 K. The company made 27,390 K in profit during its latest quarter, and -34,450 K in sales during its previous quarter.
